• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: pancreatic-cancer

  • Preoperative Chemoradiotherapy Extends Survival in Pancreatic Cancer 0
    • in AJO · Audio · Oncology
    • — 25 Jul, 2018

    Preoperative Chemoradiotherapy Extends Survival in Pancreatic Cancer

    CHICAGO—Patients with resectable and “borderline resectable” pancreatic cancers treated with chemoradiation before surgery (followed by adjuvant chemotherapy) had significantly improved outcomes compared to those randomized to have surgery first and adjuvant chemotherapy in the Dutch Pancreatic Cancer Group’sPREOPANC-1 randomized, controlled, …

    Read more
    Vantictumab Combination Benefits Patients with Stage IV Pancreatic Cancer 0
    • in Audio
    • — 31 Oct, 2016

    Vantictumab Combination Benefits Patients with Stage IV Pancreatic Cancer

    Audio Journal of Oncology

    COPENHAGEN, Denmark—In a phase 1b study patients with previously untreated stage IV pancreatic cancer responded or derived “clinical benefit” from a regimen in which a Wnt-signaling inhibitor—the humanized monoclonal antibody vantictumab—was added to nab-paclitaxel and gemcitabine …

    Read more
  • ASCO Audio Journal of Oncology – August 1st 2006 0
    • in AJO · ASCO · Oncology
    • — 30 Jul, 2006

    ASCO Audio Journal of Oncology – August 1st 2006

    John Neoptolemos
    John Neoptolemos
    Wilko Weichert
    Wilko Weichert
    Christophe Nemos
    Christophe Nemos

    Pancreatic Cancer: Adjuvant Chemotherapy Improves Outlook for Patients with Resectable Tumors – ESPAC Trial Results

    REFERENCE: National Cancer Research Institute Upper Gastrointestinal Cancer Group Studies Conference, Royal College of Physicians, London July 6th, 2006
    …
    Read more
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: pancreatic-cancer

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.